Impact of early or late intensification of glucose-lowering therapy in patients with type 2 diabetes: the global DISCOVER study

被引：0
|
作者：
Ramirez, L. [1 ]
Ji, L. [2 ]
Bonnet, F. [3 ]
Chen, H. [4 ]
Cooper, A. [5 ]
Hammar, N. [6 ,7 ]
Leigh, P. [5 ]
Saraiva, G. L. [4 ]
Medina, J. [8 ]
Nicolucci, A. [9 ]
Rathmann, W. [10 ]
Shestakova, M. V. [11 ]
Surmont, F. [1 ]
Tang, F. [12 ]
Watada, H. [13 ]
机构：
[1] AstraZeneca, Luton, Beds, England
[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[3] Univ Rennes, Rennes, France
[4] AstraZeneca, Gaithersburg, MD USA
[5] AstraZeneca, Cambridge, England
[6] Karolinska Inst, Inst Environm Med, Stockholm, Sweden
[7] AstraZeneca Moldnal, Gothenburg, Sweden
[8] AstraZeneca, Madrid, Spain
[9] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[10] Heinrich Heine Univ, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany
[11] Diabet Inst, Endocrinol Res Ctr, Moscow, Russia
[12] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[13] Juntendo Univ, Tokyo, Japan
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
295
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [1] Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study
    Ji, Linong
    Bonnet, Fabrice
    Chen, Hungta
    Cooper, Andrew
    Hammar, Niklas
    Leigh, Paul
    Saraiva, Gabriela Luporini
    Ramirez, Larisa
    Medina, Jesus
    Nicolucci, Antonio
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Surmont, Filip
    Tang, Fengming
    Watada, Hirotaka
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [2] Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
    Bongaerts, Brenda
    Arnold, Suzanne, V
    Charbonnel, Bernard H.
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Rathmann, Wolfgang
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [3] Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study
    Nicolucci, A.
    Gomes, M. B.
    Khunti, K.
    Kosiborod, M.
    Pocock, S.
    Rathmann, W.
    Shestakova, M. V.
    Shimomura, I.
    Watada, H.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Hammar, N.
    Tang, F.
    Ji, L.
    [J]. DIABETOLOGIA, 2018, 61 : S173 - S174
  • [4] Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
    Sukhareva, O. Y.
    Shestakova, M., V
    [J]. DIABETES MELLITUS, 2016, 19 (01): : 72 - 79
  • [5] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Bianchi, Cristina
    Daniele, Giuseppe
    Dardano, Angela
    Miccoli, Roberto
    Del Prato, Stefano
    [J]. DRUGS, 2017, 77 (03) : 247 - 264
  • [6] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Cristina Bianchi
    Giuseppe Daniele
    Angela Dardano
    Roberto Miccoli
    Stefano Del Prato
    [J]. Drugs, 2017, 77 : 247 - 264
  • [7] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [8] Hypertension in type 2 diabetes: impact of glucose-lowering medications
    Krentz, Andrew J.
    [J]. CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (04): : 137 - 143
  • [9] Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study
    Nicolucci, Antonio
    Chen, Hungta
    Cid-Ruzafa, Javier
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Leigh, Paul
    Medin, Jennie
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Watada, Hirotaka
    Ji, Linong
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 180
  • [10] Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: When to be cautious?
    Charbonnel, Bernard
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (01) : 3 - 5
12345